[1]
H. Su, H. Teng, and Y. Tong, “Linker Strategies in Antibody-Drug Conjugates: Insights from HER2-Targeted ADCs”, IJBLS, vol. 13, no. 2, pp. 83–91, Feb. 2026, doi: 10.54097/9j82fa18.